Search - tctmd.com

Displaying 801 - 820 of 972

Sort: Relevancy | Date

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Todd Neale

December 30, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Michael O'Riordan

December 20, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Caitlin E. Cox

December 15, 2015

News Daily News

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Caitlin E. Cox

December 08, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Daily News

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

November 30, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Daily News

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Yael L. Maxwell

October 30, 2015

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Conference News TCT 2015

FFR Guidance Remains Safe, Valuable in More Complex Disease

October 13, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

Advertisement

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

Post-TAVR Myocardial Injury Linked to Mortality

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

FFR Guidance Remains Safe, Valuable in More Complex Disease

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content